mutations in the cyp24a1 gene cause reduced serum 24,25(oh)2d3 to 25(oh)d3 ratio (<0.02), elevated serum 1,25-dihydroxyvitamin d (1,25(oh)2d3), hypercalcemia, hypercalciuria and nephrolithiasis.